Topical corticosteroids for noninvasive treatment of pyogenic granulomas. (16th July 2021)

• Record Type: Journal Article
• Authors: Moustafa, Danna; Neale, Holly; Ostrowski, Stephen M.; Gellis, Stephen E.; Hawryluk, Elena B.
• Is Part Of: Pediatric dermatology. Volume 38(2021)Supplement 2
• Page Start: 149
• Page End: 151
• Publication Date: 2021-07-16
• Subjects: autism spectrum disorder -- care for patients with intellectual disability -- corticosteroid -- noninvasive therapies -- pediatric dermatology -- pyogenic granulomas -- telemedicine; Pediatric dermatology -- Periodicals; Children -- Diseases -- Periodicals; 618.925
• DOI: 10.1111/pde.14698
• Languages: English
• ISSNs: 0736-8046

Abstract

Abstract: Pyogenic granulomas are benign vascular proliferations of the skin and mucous membranes that tend to bleed easily. They typically require procedural treatments that can be difficult for patients with intellectual disabilities or behavioral concerns to tolerate. In our practice, we have found the use of topical clobetasol to be effective to induce regression of cutaneous pyogenic granulomas. We present here a case of an adolescent patient with autism and two bleeding pyogenic granulomas who poorly tolerated a biopsy of the first lesion and could not tolerate subsequent procedures. Topical therapy with clobetasol effectively managed the second pyogenic granuloma, an approach representative of a noninvasive practice utilized in our clinic.